BMR Solutions
Bone Marrow Recovery for Chemotherapy Patients
Company Overview
Snapshot
Founded in March 2011 by Ronen Kahana and Inessa (Inna) Solomonik, BMR Solutions operates with 1–10 employees. The company is in the Pre-Funding stage and holds one patent. The company ceased operations in November 2020.
Business overview
BMR Solutions is a late preclinical-stage biopharmaceutical company focused on the discovery and development of novel compounds for the activation and enhancement of stem cells. The company's approach aims to increase the supply of bone marrow stem cells from a patient's own body to accelerate the recovery of blood parameters, including white blood cells, red blood cells, and platelets. BMR Solutions develops its most advanced drug candidate, BMRH-1001, as supportive care for cancer patients undergoing chemotherapy and/or radiation treatments who experience impaired bone marrow production and abnormal blood counts. The company operates within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Drugs Discovery & Development, serving patients and pharmaceutical companies.
Log in to access full profile ›Company Intelligence Q&A
- What is BMR Solutions' primary focus?
- BMR Solutions is a biopharmaceutical company focused on discovering and developing novel compounds to activate and enhance stem cells for treating hematological disorders caused by cancer treatments, radiation exposure, and other medical conditions.
- When was BMR Solutions founded and by whom?
- BMR Solutions was founded in March 2011 by Ronen Kahana, who serves as Co-Founder & CEO, and Inessa (Inna) Solomonik, who is the Co-Founder & CTO.
- What is the status of BMR Solutions?
- BMR Solutions is currently non-active, having ceased operations in November 2020.
- What is BMR Solutions' most advanced drug candidate?
- BMR Solutions' most advanced drug candidate is BMRH-1001, which is being developed as supportive care for cancer patients with impaired bone marrow production and abnormal blood counts, particularly those undergoing chemotherapy and/or radiation treatments.
- In which sector does BMR Solutions primarily operate?
- BMR Solutions operates primarily in the Health Tech & Life Sciences sector, with a focus on Pharma & Medical Biotechnology and Drugs Discovery & Development.